drugset / Trial / NCT02749695

Efficiency of Placental Drug Melsmon® in Correction of Climacteric Symptoms in Premenopausal Women

NCT02749695 ↗

Phase 2/3 Completed 40 enrolled Inna I. Kovalenko
RandomizedParallel-groupSingle-blindTreatment

Summary

The placental drug Melsmon® is effective for correction of insomnia and other climacteric symptoms in premenopausal women. Decrease of MMI is shown both in groups with Melsmon® and Placebo, but it was more significant in patients who used Melsmon®.

Timeline

Start
2013-10
Primary completion
2014-08
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MELSMON Unknown 2 ml Subcutaneous
Subject MELSMON Unknown 100 mg Subcutaneous

Indications

No indication recorded.